Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 1

Interventions

Cisplatin 6Paclitaxel 4pembrolizumab 3Fluorouracil 3Carboplatin 3tislelizumab 2Taxes 2Radiotherapy 2Oxaliplatin 2Leucovorin 2Irinotecan 2Injections 2Capecitabine 2130-nm albumin-bound paclitaxel 2spartalizumab 1lenvatinib 1durvalumab 1cixutumumab 1apatinib 1Tegafur 1Surgical Procedures, Operative 1Saline Solution 1Radiation 1Levoleucovorin 1Laparoscopy 1Histamine H2 Antagonists 1Histamine Antagonists 1Fulvestrant 1Docetaxel 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Tegafur × 30 days × Clear all
NCT06339619 2026-06-04

Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting
32 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡